{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:34Z","timestamp":1792800694582,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51703126"],"award-info":[{"award-number":["51703126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Start-up Fund for Excellent Doctor by Changhai Hospital","id":[{"id":"https:\/\/ror.org\/02bjs0p66","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03223-2","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T03:36:31Z","timestamp":1741232191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficient delivery of anlotinib and radioiodine by long circulating nano-capsules for active enhanced suppression of anaplastic thyroid carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Linlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-9200","authenticated-orcid":false,"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"issue":"1","key":"3223_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-022-00409-6","volume":"28","author":"L Zhang","year":"2023","unstructured":"Zhang L, Xu M, Zhang W, Zhu C, Cui Z, Fu H, Ma Y, Huang S, Cui J, Liang S, Huang L, Wang H. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type. Cell Mol Biol Lett. 2023;28(1):1.","journal-title":"Cell Mol Biol Lett"},{"issue":"7","key":"3223_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1089\/thy.2012.0359","volume":"23","author":"M Pugliese","year":"2013","unstructured":"Pugliese M, Fortunati N, Germano A, Asioli S, Marano F, Palestini N, Frairia R, Boccuzzi G, Catalano MG. Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells. Thyroid. 2013;23(7):838\u201346.","journal-title":"Thyroid"},{"issue":"3","key":"3223_CR3","doi-asserted-by":"publisher","first-page":"e2204334","DOI":"10.1002\/advs.202204334","volume":"10","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang L, Lang J, Tan Z, Feng Q, Zhu F, Liu G, Ying Z, Yu X, Feng H, Yi H, Wen Q, Jin T, Cheng K, Zhao X, Ge M. Lipid-peptide-mRNA nanoparticles augment radioiodine uptake in anaplastic thyroid cancer. Adv Sci. 2023;10(3):e2204334.","journal-title":"Adv Sci"},{"issue":"4","key":"3223_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/cancers14041061","volume":"14","author":"A Jannin","year":"2022","unstructured":"Jannin A, Escande A, Al Ghuzlan A, Blanchard P, Hartl D, Chevalier B, Deschamps F, Lamartina L, Lacroix L, Dupuy C, Baudin E. Anaplastic thyroid carcinoma: an update. Cancers. 2022;14(4):1061.","journal-title":"Cancers"},{"issue":"3","key":"3223_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/cncr.24748","volume":"116","author":"HS Kim","year":"2010","unstructured":"Kim HS, Park YH, Lee J, Ahn JS, Kim J, Shim YM, Kim JH, Park K, Han J, Ahn MJ. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray. Cancer. 2010;116(3):676\u201385.","journal-title":"Cancer"},{"key":"3223_CR6","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.2147\/OTT.S257052","volume":"13","author":"S Fang","year":"2020","unstructured":"Fang S, Cheng W, Zhang M, Yang R. Association of TP53 mutations with response to anlotinib treatment in advanced non-small cell lung cancer. Onco Targets Ther. 2020;13:6645\u201350.","journal-title":"Onco Targets Ther"},{"key":"3223_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semcancer.2020.11.013","volume":"79","author":"P Fallahi","year":"2022","unstructured":"Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Molecular targets of tyrosine kinase inhibitors in thyroid cancer. Semin Cancer Biol. 2022;79:180\u201396.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3223_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1159\/000481640","volume":"43","author":"L Liu","year":"2017","unstructured":"Liu L, Li D, Chen Z, Yang J, Ma Y, Cai H, Shan C, Lv Z, Zhang X. Wild-type P53 induces sodium\/iodide symporter expression allowing radioiodide therapy in anaplastic thyroid cancer. Cell Physiol Biochem. 2017;43(3):905\u201314.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"3223_CR9","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.21073","volume":"103","author":"RM Quiros","year":"2005","unstructured":"Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103(11):2261\u20138.","journal-title":"Cancer"},{"issue":"1","key":"3223_CR10","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1038\/s41467-019-10680-5","volume":"10","author":"SK Yoo","year":"2019","unstructured":"Yoo SK, Song YS, Lee EK, Hwang J, Kim HH, Jung G, Kim YA, Kim SJ, Cho SW, Won JK, Chung EJ, Shin JY, Lee KE, Kim JI, Park YJ, Seo JS. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer. Nat Commun. 2019;10(1):2764.","journal-title":"Nat Commun"},{"issue":"1","key":"3223_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-018-0664-7","volume":"11","author":"G Shen","year":"2018","unstructured":"Shen G, Zheng F, Ren D, Du F, Dong Q, Wang Z, Zhao F, Ahmad R, Zhao J. Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development. J Hematol Oncol. 2018;11(1):120.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3223_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/ERC-17-0558","volume":"26","author":"X Ruan","year":"2019","unstructured":"Ruan X, Shi X, Dong Q, Yu Y, Hou X, Song X, Wei X, Chen L, Gao M. Antitumor effects of anlotinib in thyroid cancer. Endocr Relat Cancer. 2019;26(1):153\u201364.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"3223_CR13","doi-asserted-by":"publisher","first-page":"e702","DOI":"10.1634\/theoncologist.2018-0839","volume":"24","author":"AP Zhou","year":"2019","unstructured":"Zhou AP, Bai Y, Song Y, Luo H, Ren XB, Wang X, Shi B, Fu C, Cheng Y, Liu J, Qin S, Li J, Li H, Bai X, Ye D, Wang J, Ma J. Anlotinib versus sunitinib as first-line treatment for metastatic renal cell carcinoma: a randomized phase II clinical trial. Oncologist. 2019;24(8):e702\u20138.","journal-title":"Oncologist"},{"issue":"19","key":"3223_CR14","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1158\/1078-0432.CCR-23-0388","volume":"29","author":"Q Xu","year":"2023","unstructured":"Xu Q, Huang K, Meng X, Weng Y, Zhang L, Bu L, Zheng X, Cai J, Zhan R, Chen Q. Safety and efficacy of anlotinib hydrochloride plus temozolomide in patients with recurrent glioblastoma. Clin Cancer Res. 2023;29(19):3859\u201366.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3223_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","volume":"161","author":"AO Elzoghby","year":"2012","unstructured":"Elzoghby AO, Samy WM, Elgindy NA. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release. 2012;161(1):38\u201349.","journal-title":"J Control Release"},{"key":"3223_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.738775","volume":"8","author":"L Guo","year":"2021","unstructured":"Guo L, Zhang H, Liu P, Mi T, Ha D, Su L, Huang L, Shi Y, Zhang J. Preclinical assessment of paclitaxel- and trastuzumab-delivering magnetic nanoparticles Fe(3)O(4) for treatment and imaging of HER2-positive breast cancer. Front Med. 2021;8: 738775.","journal-title":"Front Med"},{"key":"3223_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.actbio.2019.11.043","volume":"102","author":"Q Wang","year":"2020","unstructured":"Wang Q, Sui G, Wu X, Teng D, Zhu L, Guan S, Ran H, Wang Z, Wang H. A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics. Acta Biomater. 2020;102:367\u201383.","journal-title":"Acta Biomater"},{"issue":"3","key":"3223_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001029","volume":"10","author":"S Huang","year":"2021","unstructured":"Huang S, Zhang L, Xu M, Li C, Fu H, Huang J, Jin X, Liang S, Wang H. Co-delivery of (131) I and prima-1 by self-assembled CD44-targeted nanoparticles for anaplastic thyroid carcinoma theranostics. Adv Healthc Mater. 2021;10(3): e2001029.","journal-title":"Adv Healthc Mater"},{"issue":"93","key":"3223_CR19","doi-asserted-by":"publisher","first-page":"13608","DOI":"10.1039\/C6CC05099A","volume":"52","author":"J Li","year":"2016","unstructured":"Li J, Zhang L, Liu Y, Wen J, Wu D, Xu D, Segura T, Jin J, Lu Y, Wang H. An intracellular protein delivery platform based on glutathione-responsive protein nanocapsules. Chem Commun. 2016;52(93):13608\u201311.","journal-title":"Chem Commun"},{"key":"3223_CR20","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0036","author":"J Wu","year":"2023","unstructured":"Wu J, Liang J, Liu R, Lv T, Fu K, Jiang L, Ma W, Pan Y, Tan Z, Liu Q, Qiu W, Ge M, Wang J. Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer. Endocr Relat Cancer. 2023. https:\/\/doi.org\/10.1530\/ERC-23-0036.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"3223_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41416-021-01340-x","volume":"125","author":"J Liang","year":"2021","unstructured":"Liang J, Jin Z, Kuang J, Feng H, Zhao Q, Yang Z, Zhan L, Shen B, Yan J, Cai W, Cheng X, Qiu W. The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. Br J Cancer. 2021;125(3):390\u2013401.","journal-title":"Br J Cancer"},{"issue":"5","key":"3223_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s12094-019-02283-9","volume":"43","author":"C Wang","year":"2020","unstructured":"Wang C, Zhang R, Tan J, Meng Z, Zhang Y, Li N, Wang H, Chang J, Wang R. Effect of mesoporous silica nanoparticles co-loading with 17-AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2. Oncol Rep. 2020;43(5):1491\u2013502.","journal-title":"Oncol Rep"},{"issue":"Suppl 1","key":"3223_CR23","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/gs.2019.10.18","volume":"9","author":"SM Ferrari","year":"2020","unstructured":"Ferrari SM, Elia G, Ragusa F, Ruffilli I, La Motta C, Paparo SR, Patrizio A, Vita R, Benvenga S, Materazzi G, Fallahi P, Antonelli A. Novel treatments for anaplastic thyroid carcinoma. Gland Surg. 2020;9(Suppl 1):S28-s42.","journal-title":"Gland Surg"},{"issue":"8","key":"3223_CR24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-10-2762","volume":"17","author":"MK Gule","year":"2011","unstructured":"Gule MK, Chen Y, Sano D, Frederick MJ, Zhou G, Zhao M, Milas ZL, Galer CE, Henderson YC, Jasser SA, Schwartz DL, Bankson JA, Myers JN, Lai SY. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011;17(8):2281\u201391.","journal-title":"Clin Cancer Res"},{"issue":"15 Pt 1","key":"3223_CR25","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1158\/1078-0432.CCR-06-2636","volume":"13","author":"F Gomez-Rivera","year":"2007","unstructured":"Gomez-Rivera F, Santillan-Gomez AA, Younes MN, Kim S, Fooshee D, Zhao M, Jasser SA, Myers JN. The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model. Clin Cancer Res. 2007;13(15 Pt 1):4519\u201327.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3223_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12020-023-03390-y","volume":"81","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wang J, Ye T, Tang W, Pan X, Wang S, Liu J. Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma. Endocrine. 2023;81(3):540\u20136.","journal-title":"Endocrine"},{"issue":"13","key":"3223_CR27","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/polym14132601","volume":"14","author":"V Ejigah","year":"2022","unstructured":"Ejigah V, Owoseni O, Bataille-Backer P, Ogundipe OD, Fisusi FA, Adesina SK. Approaches to improve macromolecule and nanoparticle accumulation in the tumor microenvironment by the enhanced permeability and retention effect. Polymers. 2022;14(13):2601.","journal-title":"Polymers"},{"key":"3223_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.102915","volume":"39","author":"VR Shinde","year":"2022","unstructured":"Shinde VR, Revi N, Murugappan S, Singh SP, Rengan AK. Enhanced permeability and retention effect: a key facilitator for solid tumor targeting by nanoparticles. Photodiagn Photodyn Ther. 2022;39: 102915.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"2","key":"3223_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.20892\/j.issn.2095-3941.2019.0292","volume":"17","author":"C Yang","year":"2020","unstructured":"Yang C, Tan Y, Qi H, Zhou J, Long L, Zhan Q, Wang Y, Yuan X, Kang C. Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab. Cancer Biol Med. 2020;17(2):433\u201343.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"3223_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/21691401.2021.1871620","volume":"49","author":"X Zou","year":"2021","unstructured":"Zou X, Jiang Z, Li L, Huang Z. Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer. Artificial Cells Nanomed Biotechnol. 2021;49(1):83\u201395.","journal-title":"Artificial Cells Nanomed Biotechnol"},{"issue":"17","key":"3223_CR31","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.7150\/thno.49577","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi Y, van der Meel R, Chen X, Lammers T. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy. Theranostics. 2020;10(17):7921\u20134.","journal-title":"Theranostics"},{"issue":"1","key":"3223_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201901223","volume":"9","author":"H Kang","year":"2020","unstructured":"Kang H, Rho S, Stiles WR, Hu S, Baek Y, Hwang DW, Kashiwagi S, Kim MS, Choi HS. Size-dependent EPR effect of polymeric nanoparticles on tumor targeting. Adv Healthcare Mater. 2020;9(1): e1901223.","journal-title":"Adv Healthcare Mater"},{"issue":"5","key":"3223_CR33","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00259-021-05605-8","volume":"49","author":"S Schumann","year":"2022","unstructured":"Schumann S, Scherthan H, Pfestroff K, Schoof S, Pfestroff A, Hartrampf P, Hasenauer N, Buck AK, Luster M, Port M, Lassmann M, Eberlein U. DNA damage and repair in peripheral blood mononuclear cells after internal ex vivo irradiation of patient blood with (131)I. Eur J Nucl Med Mol Imaging. 2022;49(5):1447\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"108","key":"3223_CR34","doi-asserted-by":"publisher","first-page":"88560","DOI":"10.1039\/C5RA12804H","volume":"5","author":"S Liang","year":"2015","unstructured":"Liang S, Jin X, Ma Y, Guo J, Wang H. Folic acid-conjugated BSA nanocapsule (n-BSA\u2013FA) for cancer targeted radiotherapy and imaging. RSC Adv. 2015;5(108):88560\u20136.","journal-title":"RSC Adv"},{"issue":"1","key":"3223_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41392-023-01672-5","volume":"8","author":"Y Han","year":"2023","unstructured":"Han Y, Wang J, Sun T, Ouyang Q, Li J, Yuan J, Xu B. Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. Signal Transduct Target Ther. 2023;8(1):429.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3223_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nnano.2012.264","volume":"8","author":"Y Liu","year":"2013","unstructured":"Liu Y, Du J, Yan M, Lau MY, Hu J, Han H, Yang OO, Liang S, Wei W, Wang H, Li J, Zhu X, Shi L, Chen W, Ji C, Lu Y. Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication. Nat Nanotechnol. 2013;8(3):187\u201392.","journal-title":"Nat Nanotechnol"},{"issue":"8","key":"3223_CR37","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1039\/C5NR06756A","volume":"8","author":"R Prasad","year":"2016","unstructured":"Prasad R, Aiyer S, Chauhan DS, Srivastava R, Selvaraj K. Bioresponsive carbon nano-gated multifunctional mesoporous silica for cancer theranostics. Nanoscale. 2016;8(8):4537\u201346.","journal-title":"Nanoscale"},{"key":"3223_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.colsurfb.2018.08.054","volume":"172","author":"DS Chauhan","year":"2018","unstructured":"Chauhan DS, Kumawat MK, Prasad R, Reddy PK, Dhanka M, Mishra SK, Bahadur R, Neekhra S, De A, Srivastava R. Plasmonic carbon nanohybrids for repetitive and highly localized photothermal cancer therapy, colloids and surfaces. B, Biointerfaces. 2018;172:430\u20139.","journal-title":"B, Biointerfaces"},{"issue":"2","key":"3223_CR39","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1021\/acsabm.0c01478","volume":"4","author":"R Prasad","year":"2021","unstructured":"Prasad R, Jain NK, Yadav AS, Jadhav M, Radharani NNV, Gorain M, Kundu GC, Conde J, Srivastava R. Ultrahigh penetration and retention of graphene quantum dot mesoporous silica nanohybrids for image guided tumor regression. ACS Appl Bio Mater. 2021;4(2):1693\u2013703.","journal-title":"ACS Appl Bio Mater"},{"issue":"12","key":"3223_CR40","doi-asserted-by":"publisher","first-page":"2110575","DOI":"10.1002\/adfm.202110575","volume":"32","author":"AK Bindra","year":"2022","unstructured":"Bindra AK, Sreejith S, Prasad R, Gorain M, Thomas R, Jana D, Nai MH, Wang D, Tharayil A, Kundu GC, Srivastava R, Thomas S, Lim CT, Zhao Y. A plasmonic supramolecular nanohybrid as a contrast agent for site-selective computed tomography imaging of tumor. Adv Funct Mater. 2022;32(12):2110575.","journal-title":"Adv Funct Mater"},{"issue":"2","key":"3223_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1166\/jbn.2018.2485","volume":"14","author":"R Li","year":"2018","unstructured":"Li R, Yan J, Xie L, Zhang Y, Gao J, Liu Q, Lin Z, Jiang P, Qian H, Yang M, Wu F, Jiang X, Liu B, Wang L. Facile optimization and evaluation of PEG-PCL block copolymeric nanoparticles for anticancer drug delivery using copolymer hybrids and histoculture drug response assays. J Biomed Nanotechnol. 2018;14(2):321\u201330.","journal-title":"J Biomed Nanotechnol"},{"issue":"48","key":"3223_CR42","doi-asserted-by":"publisher","first-page":"15217","DOI":"10.1021\/jacs.5b09602","volume":"137","author":"CY Sun","year":"2015","unstructured":"Sun CY, Shen S, Xu CF, Li HJ, Liu Y, Cao ZT, Yang XZ, Xia JX, Wang J. Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery. J Am Chem Soc. 2015;137(48):15217\u201324.","journal-title":"J Am Chem Soc"},{"issue":"8","key":"3223_CR43","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1007\/s12274-016-1128-4","volume":"9","author":"L Zhang","year":"2016","unstructured":"Zhang L, Liu Y, Liu G, Xu D, Liang S, Zhu X, Lu Y, Wang H. Prolonging the plasma circulation of proteins by nano-encapsulation with phosphorylcholine-based polymer. Nano Res. 2016;9(8):2424\u201332.","journal-title":"Nano Res"},{"issue":"4","key":"3223_CR44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s12274-016-0991-3","volume":"9","author":"S Liang","year":"2016","unstructured":"Liang S, Liu Y, Jin X, Liu G, Wen J, Zhang L, Li J, Yuan X, Chen ISY, Chen W, Wang H, Shi L, Zhu X, Lu Y. Phosphorylcholine polymer nanocapsules prolong the circulation time and reduce the immunogenicity of therapeutic proteins. Nano Res. 2016;9(4):1022\u201331.","journal-title":"Nano Res"},{"key":"3223_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.humpath.2016.10.020","volume":"61","author":"J Jankovi\u0107","year":"2017","unstructured":"Jankovi\u0107 J, Tati\u0107 S, Bo\u017ei\u0107 V, \u017divaljevi\u0107 V, Cveji\u0107 D, Paska\u0161 S. Inverse expression of caveolin-1 and EGFR in thyroid cancer patients. Hum Pathol. 2017;61:164\u201372.","journal-title":"Hum Pathol"},{"issue":"5","key":"3223_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.trsl.2014.06.005","volume":"164","author":"Z Milosevic","year":"2014","unstructured":"Milosevic Z, Pesic M, Stankovic T, Dinic J, Milovanovic Z, Stojsic J, Dzodic R, Tanic N, Bankovic J. Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma. Transl Res. 2014;164(5):411\u201323.","journal-title":"Transl Res"},{"key":"3223_CR47","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.2147\/OTT.S84625","volume":"9","author":"L Lorusso","year":"2016","unstructured":"Lorusso L, Pieruzzi L, Biagini A, Sabini E, Valerio L, Giani C, Passannanti P, Pontillo-Contillo B, Battaglia V, Mazzeo S, Molinaro E, Elisei R. Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer. Onco Targets Ther. 2016;9:6467\u201377.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"3223_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/jcp.2006.041251","volume":"60","author":"DH Lee","year":"2007","unstructured":"Lee DH, Lee GK, Kong SY, Kook MC, Yang SK, Park SY, Park SH, Keam B, Park DJ, Cho BY, Kim SW, Chung KW, Lee ES, Kim SW. Epidermal growth factor receptor status in anaplastic thyroid carcinoma. J Clin Pathol. 2007;60(8):881\u20134.","journal-title":"J Clin Pathol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03223-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03223-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T04:03:50Z","timestamp":1741233830000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03223-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3223"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03223-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All samples were anonymously coded according to the local ethical guidelines as stipulated by the Declaration of Helsinki. Written informed consent was obtained from all the patients, and this study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine\u00a0and each participating center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"180"}}